About ARVN

Arvinas is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses their proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ARVN is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
EQWS Invesco Russell 2000 Equal Weight ETF 19.8 M 1.98E+07 1,952 1952 0.03% 0.00029 6 K 5626
IWC iShares Microcap ETF 902.6 M 9.02588E+08 1,461 1461 0.04% 0.0004 337 K 337070
IWM iShares Russell 2000 ETF 41.6 B 4.16227E+10 2,023 2023 0.01% 0.0001 2.7 M 2678470
IWN iShares Russell 2000 Value ETF 9.2 B 9.20642E+09 1,381 1381 0.0% 0 202 K 201778
IWO iShares Russell 2000 Growth ETF 8.7 B 8.73602E+09 1,249 1249 0.01% 0.0001 929 K 929373
URTY ProShares UltraPro Russell2000 112.3 M 1.12258E+08 2,034 2034 0.0% 1.2318E-05 5 K 4656
UWM ProShares Ultra Russell2000 140.5 M 1.40506E+08 2,034 2034 0.0% 2.83148E-05 8 K 8313
DESC Xtrackers Russell 2000 Comprehensive Factor ETF 9.5 M 9513210 1,503 1503 0.01% 0.000149069 1 K 1418

Wait, Before You Leave...